Kraig Biocraft Q3 2026: Going Concern Reiterated, $3.1M Nine-Month Loss, Cash Up to $2.78M
KBLB sits 22% above its 52-week low of $0.065.
Summary
Kraig Biocraft's Q3 2026 10-Q shows a $3.1M nine-month net loss, a $8.1M working capital deficit and a repeated going concern warning, funded entirely by continued share sales under its $10M standby equity facility.
Key Events · Earnings and Guidance · KBLB
-
Going Concern Doubt Reiterated
Working capital deficiency of $8,110,368 and stockholders' deficiency of $7,502,437, with $1,722,595 of cash used in operations for the nine months ended September 30, 2026.
-
Nine-Month Net Loss Widens
Net loss of $3,095,751 for the nine months ended September 30, 2026 versus $2,835,732 a year earlier; Q3 loss narrowed to $1,243,496 from $1,509,566.
-
SEPA Keeps Funding Operations
Sold 25,364,093 shares for $2,772,547 in the nine months, plus 1,547,572 shares for $120,544 in October-November 2026; $10 million facility remains the primary funding source.
-
Cash Rises to $2.78M
Cash and equivalents of $2,783,802 at September 30, 2026, up from $1,790,236 at December 31, 2025, funded by equity sales rather than operations.
Analysis · KBLB · Industrial Applications And Services
The company still cannot fund itself from operations: it burned $1,722,595 of cash in the first nine months of 2026 and carries a working capital deficit of $8,110,368, so management repeats that substantial doubt exists about continuing as a going concern. The lifeline is the Standby Equity Purchase Agreement with YA II PN, which has already supplied $2,772,547 from 25,364,093 shares in the nine months and a further $120,544 from 1,547,572 shares in October-November 2026 — cash that lifted the balance to $2,783,802 but keeps diluting holders. Revenue is still essentially nil at $3,000 for the quarter, and management also disclosed that disclosure controls and procedures were not effective at September 30, 2026.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KBLB was trading at $0.08 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $88.7M. The 52-week trading range was $0.07 to $0.16. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.